NEWRON PHARMACEUTICALS S.P.A.

Transcripts Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Delayed Swiss Exchange Other stock markets 10:11:37 2024-05-03 am EDT			5-day change	1st Jan Change
9.09 ^CHF	+9.39%		+28.71%	+82.02%

Apr. 30	Newron Pharmaceuticals S.p.A. Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients	CI
Apr. 17	Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Newron Pharmaceuticals S.p.A., 2023 Earnings Call, Mar 19, 2024	Mar. 19
Transcript : Newron Pharmaceuticals S.p.A. - Special Call	Jan. 04
Transcript : Newron Pharmaceuticals S.p.A., 2022 Earnings Call, Mar 14, 2023	23-03-14
Transcript : Newron Pharmaceuticals S.p.A. - Shareholder/Analyst Call	23-02-16
Transcript : Newron Pharmaceuticals S.p.A. - Shareholder/Analyst Call	23-01-03
Transcript : Newron Pharmaceuticals S.p.A. - Special Call	22-06-07
Transcript : Newron Pharmaceuticals S.p.A., 2021 Earnings Call, Mar 15, 2022	22-03-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer